ACE2 and COVID-19: In a previous paper, we hypothesized that a worse outcome of COVID-19 in people with diabetes mellitus could be related to the non-enzymatic glycation of human ACE2, which could trigger the activity of ACE2 to a more susceptible interaction with virus Spike protein14.